Assignee
SPINALCYTE LLC
US·14 granted patents·16 pending applications·56 citations·filing 2007–2025
Top patents by PatentIndex Score
30 records- 0196US7850983B2Methods and compositions for repair of cartilage using an in vivo bioreactorSPINALCYTE LLC·Filed 2007·Granted Dec 14, 2010·44 cites·52 claims
- 0290US11034934B2Methods of enhancing fibroblast therapeutic activitySPINALCYTE LLC·Filed 2018·Granted Jun 15, 2021·7 cites·13 claims
- 0388US2023338617A1Methods and compositions for repair of cartilage using an in vivo bioreactorSPINALCYTE LLC·Filed 2023·Application pending·0 cites
- 0487US11717596B2Methods and compositions for repair of cartilage using an in vivo bioreactorSPINALCYTE LLC·Filed 2020·Granted Aug 8, 2023·1 cites·5 claims
- 0584US12090174B2Fibroblast therapy for treatment of Duchenne muscular dystrophySPINALCYTE LLC·Filed 2020·Granted Sep 17, 2024·1 cites·23 claims
- 0682US12133870B2Treatment of opioid addiction using fibroblasts and products thereofSPINALCYTE LLC·Filed 2020·Granted Nov 5, 2024·1 cites·31 claims
- 0779US2025041352A1Treatment of opioid addiction using fibroblasts and products thereofSPINALCYTE LLC·Filed 2024·Application pending·0 cites
- 0878US12310991B2Stimulation of angiogenesis by fibroblast derived exosomesSPINALCYTE LLC·Filed 2018·Granted May 27, 2025·1 cites·32 claims
- 0976US2025041351A1Fibroblast therapy for treatment of duchenne muscular dystrophySPINALCYTE LLC·Filed 2024·Application pending·0 cites
- 1072US2023407259A1De-differentiated fibroblast-conditioned media for stimulation of disc regenerationSPINALCYTE LLC·Filed 2023·Application pending·0 cites
- 1169US10206954B2Adipose cells for chondrocyte applicationsSPINALCYTE LLC·Filed 2014·Granted Feb 19, 2019·1 cites·50 claims
- 1269US2022047644A1Fibroblasts for treatment of degenerative disc diseaseSPINALCYTE LLC·Filed 2021·Application pending·0 cites
- 1366US12233094B2Interaction of fibroblasts and immune cells for activation and uses thereofSPINALCYTE LLC·Filed 2018·Granted Feb 25, 2025·0 cites·13 claims
- 1466US10052410B2Methods and compositions for repair of cartilage using an in vivo bioreactorSPINALCYTE LLC·Filed 2016·Granted Aug 21, 2018·0 cites·22 claims
- 1565US10806824B2Methods and compositions for repair of cartilage using an in vivo bioreactorSPINALCYTE LLC·Filed 2018·Granted Oct 20, 2020·0 cites·11 claims
- 1664US12576112B2Inhibition of TNF-alpha by fibroblasts and fibroblast exosomesSPINALCYTE LLC·Filed 2020·Granted Mar 17, 2026·0 cites·17 claims
- 1764US12404494B2Prevention of recurrent miscarriages through administration of fibroblasts and fibroblast-educated paternal cellsSPINALCYTE LLC·Filed 2020·Granted Sep 2, 2025·0 cites·22 claims
- 1862US12544408B2Prevention and treatment of kidney failure by administration of fibroblasts and products thereofSPINALCYTE LLC·Filed 2020·Granted Feb 10, 2026·0 cites·22 claims
- 1962US12508287B2Treatment of cerebral palsy using fibroblastsSPINALCYTE LLC·Filed 2021·Granted Dec 30, 2025·0 cites·11 claims
- 2062US2025144151A1Interaction of fibroblasts and immune cells for activation and uses thereofSPINALCYTE LLC·Filed 2025·Application pending·0 cites
- 2162US2021309971A1Methods of enhancing fibroblast therapeutic activitySPINALCYTE LLC·Filed 2021·Application pending·0 cites
- 2262US2023158080A1Hormonal manipulation of fibroblast therapeutic activitySPINALCYTE LLC·Filed 2022·Application pending·0 cites
- 2362US2021130784A1De-differentiated fibroblast-conditioned media for stimulation of disc regenerationSPINALCYTE LLC·Filed 2019·Application pending·0 cites
- 2460US2024269192A1Fibroblast based therapeutics of amyotrophic lateral sclerosisSPINALCYTE LLC·Filed 2022·Application pending·0 cites
- 2555US2023201269A1Treatment of frontotemporal dementia using fibroblasts and products thereofSPINALCYTE LLC·Filed 2021·Application pending·0 cites
- 2654US2018236005A1Fibroblasts for treatment of degenerative disc diseaseSPINALCYTE LLC·Filed 2018·Application pending·0 cites
- 2752US2014314726A1Fibroblasts for treatment of degenerative disc diseaseSPINALCYTE LLC·Filed 2012·Application pending·0 cites
- 2851US2021154230A1Intradiscal t-regulatory cell administration for treatment of disc degenerative diseaseSPINALCYTE LLC·Filed 2019·Application pending·0 cites
- 2945US2021230551A1Enhancement of fibroblast plasticity for treatment of disc degenerationSPINALCYTE LLC·Filed 2019·Application pending·0 cites
- 3037US2019022145A1Cellular blend for the regeneration of chondrocytes or cartilage type cellsSPINALCYTE LLC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →